Indian Council of Medical Research

Indian Council of Medical Research ▸ Facts ▸ Comments ▸ News ▸ Videos

The Indian Council of Medical Research (ICMR), the apex body in India for the formulation, coordination and promotion of biomedical research, is one of the oldest and largest medical research bodies in the world. The ICMR is funded by the Government of India through the Department of Health Research, Ministry of Health and Family Welfare. In 2007 the organization established the Clinical Trials Registry - India, which is India's national registry for clinical trials.

0 shares	Share Tweet Save Post Send



India records 10,064 new COVID cases in last 24 hours As per the data released by Ministry of Health and Family Welfare (MoHFW), India on January 19 reported single-day spike of 10,064 new coronavirus cases in the last 24 hours. 137 deaths in the same.. Credit: ANI Duration: 01:12Published 6 days ago

India records 13,788 new COVID cases in last 24 hours As per the data released by Ministry of Health and Family Welfare (MoHFW), India on January 18 reported single-day spike of 13,788 new coronavirus cases in the last 24 hours. 145 deaths in the same.. Credit: ANI Duration: 01:26Published 1 week ago

COVID-19: Total cases cross 1.05 crore-mark in India On January 16, total COVID-19 tally of India reached to 1,05,42,841. The country reported 15,158 new COVID-19 cases in last 24 hours and active cases stands at 2,11,033. With new 16,977 discharges,.. Credit: ANI Duration: 01:52Published 1 week ago

COVID-19: Active cases in India dip to 2,10,l06 On January 15, India reported 15,677 new COVID-19 cases and 189 deaths in last 24 hours. The active cases stands at 2,10,l06. With new 15,848 discharges, total number reached to 1,01,62,082. 189 deaths.. Credit: ANI Duration: 01:45Published 1 week ago

‘Covaxin will also provide immunity against Covid mutants’: ICMR scientist Dr Samiran Panda, scientist, India Council of Medical Research (ICMR) said that Bharat Biotech’s Covaxin will also provide immunity against covid-19 mutants. Panda added that India has taken a smart.. Credit: HT Digital Content Duration: 04:36Published 2 weeks ago

Covishield and Covaxin are safe, assures ICMR scientist Indian Council of Medical Research, Scientist and Head of Epidemiology and Communicable Diseases Division, Dr. Samiran Panda while speaking to ANI assured that both Covishield and Covaxin are safe and.. Credit: ANI Duration: 02:29Published 2 weeks ago

Covaxin's immunity will address mutants too: ICMR scientist Indian Council of Medical Research, Scientist and Head of Epidemiology and Communicable Diseases Division, Dr. Samiran Panda said that the immunity produced by the Covaxin is expected to address the.. Credit: ANI Duration: 01:24Published 2 weeks ago

India records 15,968 new COVID cases in last 24 hours On January 13, the total COVID-19 tally of India reached to 1,04,95,147. The country reported 15,968 new COVID-19 cases in last 24 hours and active cases stands at 2,14,507. With new 17,817 discharges,.. Credit: ANI Duration: 01:33Published 2 weeks ago

COVID-19: Active cases dip to 2.16 lakh in India On January 12, the total COVID-19 tally of India reached to 1,04,79,179. The country reported 12,584 new COVID-19 cases in last 24 hours and the active cases stands at 2,16,558. With new 18,385.. Credit: ANI Duration: 01:39Published 2 weeks ago

India records 16,311 new COVID cases in last 24 hours As per the data released by Ministry of Health and Family Welfare (MoHFW), India on January 11 reported single-day spike of 16,311 new coronavirus cases in the last 24 hours. 161 deaths in the same.. Credit: ANI Duration: 01:48Published 2 weeks ago

India reports 18,645 new COVID-19 infections, 19,299 recoveries in last 24 hours India on January 10 reported 18,645 new COVID-19 cases, 19,299 recoveries in last 24 hours. The total number of COVID-19 cases now stands at 1,04,50,284, which includes 2,23,335 active cases. The total.. Credit: ANI Duration: 01:38Published 2 weeks ago

COVID: Active cases dip to 2.25 lakh in India India on January 08 reported 18,139 new COVID-19 infections, taking the country's count to over 1.04 crores. The total number of COVID-19 cases now stands at 1,04,13,417, including 2,25,449 active.. Credit: ANI Duration: 01:39Published 2 weeks ago

India's COVID-19 recoveries cross 1 crore mark India on January 07 reported 20,346 new COVID-19 cases, 19,587 recoveries in last 24 hours, taking the country's count to more than 1.03 crore. The total number of COVID-19 cases now stands at.. Credit: ANI Duration: 01:42Published 3 weeks ago

Everyone will give their consent for vaccine, there'll be no placebo: ICMR While addressing a joint press conference in the national capital on January 05, Secretary DHR and Director General of Indian Council of Medical Research (ICMR), Professor Balram Bhargava said, "Drug.. Credit: ANI Duration: 01:47Published 3 weeks ago

You Might Like

Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study India's first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the.. IndiaTimes - Published 2 days ago
Vaccine drive accelerates, doses reach far corners of India While SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and.. IndiaTimes - Published 2 weeks ago
No irregularity in approval to Covaxin: ICMR In an urgent situation like the Covid pandemic, the drug regulator has the authority to give approval for restricted use to a vaccine based on its safety and immunogenicity data from phase 1 and 2.. IndiaTimes - Published 3 weeks ago

All-India vaccine rollout set for next week: Govt The government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian.. IndiaTimes - Published 3 weeks ago
During pandemic, vaccine's restricted use considered based on safety, immunogenicity data: ICMR chief IndiaTimes - Published 3 weeks ago
Emergency use of vaccine is based on safety, immunogenicity data, says ICMR chief The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and.. IndiaTimes - Published 3 weeks ago

From abroad, Rahul directing Cong rumour-mongering: BJP Intensifying attack on Congress for questioning the DCGI’s approval to Covid vaccines, BJP on Monday said Rahul Gandhi, while on a vacation abroad, choreographed rumour-mongering by enlisting his.. IndiaTimes - Published 3 weeks ago
ICMR says clinical trial shows COVAXIN is 'safe' Notably, COVAXIN is an indigenously developed coronavirus vaccine manufactured by Bharat Biotech in collaboration with the ICMR. DNA - Published 3 weeks ago
In a 1st, NIV-Pune isolates, cultures Covid's UK variant Pune's National Institute of Virology (NIV) has isolated and cultured the new UK variant of SARS-CoV2, the Indian Council of Medical Research (ICMR) said on Saturday underlining that no other country.. IndiaTimes - Published 3 weeks ago
India successfully cultures UK-variant of Sars-CoV-2: ICMR IndiaTimes - Published 3 weeks ago

ICMR-RMRC study on use of saliva for SARS-CoV-2 test shows promise IndiaTimes - Published 3 weeks ago
Careless use of therapies may lead to mutations, says ICMR The Indian Council of Medical Research (ICMR) warned against non-judicious use of therapies that have not been established for treating Covid-19 because it can lead to immune pressure on SARS-CoV2.. IndiaTimes - Published on December 29, 2020
Non-judicious use of therapies for Covid-19 leads to virus mutations: ICMR chief "Those therapies which are being touted as 'anti-viral' or 'anti-Covid therapies' and they have do not have benefits established in a scientific research paper, those therapies should not be used as.. IndiaTimes - Published on December 29, 2020	3rd serosurvey to cover health workers: ICMR A third Covid-19 serosurvey by the Indian Council of Medical Research is set to assess the infection’s spread among health workers in India. The survey, which began on Thursday, is expected to.. IndiaTimes - Published on December 26, 2020
Bharat Biotech bosses discuss Covaxin status with Vice President M Venkaiah Naidu They discussed the status of the indigenous vaccine, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology, and the plans.. IndiaTimes - Published on December 25, 2020Also reported by •DNA	Indian vaccine Covaxin has drawn global attention: ICMR The Indian Council of Medical Research (ICMR) has said that the Indian vaccine against Covid-19, Covaxin, has drawn global attention. In a tweet, the ICMR said, "India's indigenous vaccine against.. IndiaTimes - Published on December 24, 2020
New coronavirus strain not found in samples tested in India, says ICMR-NARI director The director said that 7 to 11 sub-types of coronavirus are already known but not each one that is identified needs to be seen with panic. DNA - Published on December 23, 2020	DNA Analysis: How air pollution is bigger threat than we perceive ICMR has released statistics on deaths from pollution. According to these figures, in 2019, 16 lakh deaths have occurred due to pollution in India. DNA - Published on December 23, 2020
‘Pollution killed 1.7m in India in 2019, behind 18% of all deaths’ Air pollution killed nearly 1.7 million people in India in 2019, accounting for an alarming 17.8% of all deaths in the country in the year, a new paper written as a collaborative effort by Indian.. IndiaTimes - Published on December 22, 2020	ICMR chief Balram Bhargava admitted to AIIMS after testing positive for COVID-19 This comes as India's COVID-19 caseload rose to 99.79 lakh with 22,890 new infections being reported in a day. DNA - Published on December 18, 2020
ICMR chief Balram Bhargava undergoing treatment for Covid-19 at AIIMS Trauma Centre Indian Council of Medical Research (ICMR) Director General Balram Bhargava is undergoing treatment for Covid-19 at the AIIMS Trauma Centre here, official sources said on Friday. Bhargava, who is also a.. IndiaTimes - Published on December 18, 2020	Entire population may not need to be vaccinated: ICMR Dr Bhargava and health secretary Rajesh Bhushan also said a decision is yet to be taken on whether those who have been infected by the disease and recovered need to be administered the vaccine. While.. IndiaTimes - Published on December 1, 2020
‘Adverse event’ won’t affect vaccine rollout plan: Government ICMR director general Dr Balram Bhargava said adverse events occur with drugs, vaccines or any other health interventions. It is the role of the regulator after collating all the data to ascertain or.. IndiaTimes - Published on December 1, 2020	PM Modi reaches Hyderabad to visit Bharat Biotech plant PM Modi will be proceeding to Bharat Biotech's facility located at Genome valley, a life sciences cluster about 20 km from the AF base, officials said. Covid-19 vaccine, Covaxin, being developed.. IndiaTimes - Published on November 28, 2020
ICMR nod for CCMB's dry swab testing for Covid-19 IndiaTimes - Published on November 27, 2020	India had estimated 74 million Covid-19 infections by August: ICMR's 2nd national serosurvey IndiaTimes - Published on November 26, 2020
13 crore Covid-19 tests done so far, cumulative positivity rate falling steadily: Health ministry According to the Indian council of medical research (ICMR), over 13.06 crore samples have been tested till November 20 with 10,66,022 being tested on Friday. Higher volumes of testing eventually lead.. IndiaTimes - Published on November 21, 2020	Troubling trend: India test numbers fall, RAT share remains high Widespread use of RAT, in some cases up to 90% of all tests, has raised fears that a large number of positive cases could be missed. As per the ICMR protocol, every positive report from RAT can be.. IndiaTimes - Published on November 19, 2020
Covid-19: Indiscriminate use of Convalescent Plasma Therapy not advisable, says ICMR IndiaTimes - Published on November 18, 2020	First time since August, daily tests below 9 lakh for 3 days Daily Covid-19 cases in India rose to over 38,000 on Tuesday after dropping below 30,000 the previous day but the number of tests conducted in the country continued to remain low for the fourth day.. IndiaTimes - Published on November 17, 2020
Third wave in Covid-19 cases has come now in Delhi: ICMR A third spike in Covid-19 cases has come now in Delhi which is showing more cases than before, with factors like pollution, cold weather and festivals playing a major role in the rise of the.. IndiaTimes - Published on November 10, 2020	India-made COVID-19 vaccine could be launched as early as this month, know when Bharat Biotech, a private company that is developing COVAXIN with the government-run Indian Council of Medical Research (ICMR), had earlier hoped to launch it only in the second quarter of next year. DNA - Published on November 5, 2020
Bharat Biotech to launch Covaxin in Q2 2021 Bharat Biotech is planning to launch its vaccine for Covid-19 in the second quarter next year if it gets the requisite approvals from the Indian regulatory authorities, a top company official said. The.. IndiaTimes - Published on November 1, 2020	BCG vaccine could help elderly fight Covid: ICMR The nearly century-old Bacille Calmette-Guérin (BCG) vaccine can help the elderly fight off infections such as Covid-19, a study by the Indian Council of Medical Research has said. The researchers.. IndiaTimes - Published on October 29, 2020
Some evidence shows children could be Covid spreaders: ICMR IndiaTimes - Published on October 27, 2020	COVID-19 vaccine: Phase 3 of human trial of Covaxin to begin at Odisha's SUM hospital soon A total of 21 medical institutes were selected across the country by the Indian Council for Medical Research (ICMR) where the third phase trial would be conducted. DNA - Published on October 26, 2020
ICMR issues advisory for use of Feluda paper strip test The paper-strip uses cutting-edge CRISPR gene-editing technology to identify and target the genetic material of SARS-CoV-2, the virus that causes Covid-19 in less than an hour. As claimed by the.. IndiaTimes - Published on October 23, 2020	'Tum mujhe vote do,hum tumhe vaccine denge': Shiv Sena's Sanjay Raut on BJP's Bihar polls manifesto The Bharatiya Janata Party (BJP) on Thursday released its manifesto for three-phased Bihar elections and promised that after approval of coronavirus vaccine from ICMR, every person in the state will.. DNA - Published on October 23, 2020
India crosses 10 cr-mark in conducting Covid-19 tests: ICMR IndiaTimes - Published on October 23, 2020	ICMR issues advisory on CRISPR technology-based SARS CoV-2 test The Indian Council of Medical Research (ICMR) on Thursday issued an advisory on the CRISPR SARS CoV-2 test that has been approved by the Drugs Controller General of India for Covid-19 detection. As.. IndiaTimes - Published on October 23, 2020
ICMR could derail world’s largest trial IndiaTimes - Published on October 23, 2020	Odisha, Goa swear by plasma therapy despite ICMR’s note IndiaTimes - Published on October 23, 2020
Free Covid vaccine, 19 lakh jobs: BJP releases Bihar manifesto Bharatiya Janata Party (BJP) on Thursday released its manifesto for the three-phased Bihar elections promising to distribute the coronavirus vaccine free of cost once approved by the ICMR, and also.. IndiaTimes - Published on October 22, 2020	IIT Kharagpur's 'Covirap' diagnostic machine gets ICMR certification IndiaTimes - Published on October 21, 2020
Plasma therapy is likely to be off Covid treatment protocol: ICMR IndiaTimes - Published on October 21, 2020	Virus can hit recovered Covid patients once antibodies start depleting: ICMR IndiaTimes - Published on October 20, 2020
‘Post Trials’ data, ICMR needs to revise Covid-19 drug regimen’ IndiaTimes - Published on October 17, 2020	ICMR: Three re-infection cases in India, 24 globally IndiaTimes - Published on October 13, 2020
DCGI nod to Phase-1 human trials of 'antisera' with potential to treat Covid-19 The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a.. IndiaTimes - Published on October 6, 2020	No benefit of plasma therapy arresting mortality in moderate to severe Covid-19 cases: ICMR Addressing a press conference here Bhargava said, "An ICMR study has clearly established no benefit of plasma therapy in arresting mortality in moderate to severe cases of Covid-19. Following a cue.. IndiaTimes - Published on October 6, 2020

Indian Council of Medical Research

Indian Council of Medical Research ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study

Vaccine drive accelerates, doses reach far corners of India

No irregularity in approval to Covaxin: ICMR

All-India vaccine rollout set for next week: Govt

During pandemic, vaccine's restricted use considered based on safety, immunogenicity data: ICMR chief

Emergency use of vaccine is based on safety, immunogenicity data, says ICMR chief

From abroad, Rahul directing Cong rumour-mongering: BJP

ICMR says clinical trial shows COVAXIN is 'safe'

In a 1st, NIV-Pune isolates, cultures Covid's UK variant

India successfully cultures UK-variant of Sars-CoV-2: ICMR

ICMR-RMRC study on use of saliva for SARS-CoV-2 test shows promise

Careless use of therapies may lead to mutations, says ICMR

Non-judicious use of therapies for Covid-19 leads to virus mutations: ICMR chief

3rd serosurvey to cover health workers: ICMR

Bharat Biotech bosses discuss Covaxin status with Vice President M Venkaiah Naidu

Indian vaccine Covaxin has drawn global attention: ICMR

New coronavirus strain not found in samples tested in India, says ICMR-NARI director

DNA Analysis: How air pollution is bigger threat than we perceive

‘Pollution killed 1.7m in India in 2019, behind 18% of all deaths’

ICMR chief Balram Bhargava admitted to AIIMS after testing positive for COVID-19

ICMR chief Balram Bhargava undergoing treatment for Covid-19 at AIIMS Trauma Centre

Entire population may not need to be vaccinated: ICMR

‘Adverse event’ won’t affect vaccine rollout plan: Government

PM Modi reaches Hyderabad to visit Bharat Biotech plant

ICMR nod for CCMB's dry swab testing for Covid-19

India had estimated 74 million Covid-19 infections by August: ICMR's 2nd national serosurvey

13 crore Covid-19 tests done so far, cumulative positivity rate falling steadily: Health ministry

Troubling trend: India test numbers fall, RAT share remains high

Covid-19: Indiscriminate use of Convalescent Plasma Therapy not advisable, says ICMR

First time since August, daily tests below 9 lakh for 3 days

Third wave in Covid-19 cases has come now in Delhi: ICMR

India-made COVID-19 vaccine could be launched as early as this month, know when

Bharat Biotech to launch Covaxin in Q2 2021

BCG vaccine could help elderly fight Covid: ICMR

Some evidence shows children could be Covid spreaders: ICMR

COVID-19 vaccine: Phase 3 of human trial of Covaxin to begin at Odisha's SUM hospital soon

ICMR issues advisory for use of Feluda paper strip test

'Tum mujhe vote do,hum tumhe vaccine denge': Shiv Sena's Sanjay Raut on BJP's Bihar polls manifesto

India crosses 10 cr-mark in conducting Covid-19 tests: ICMR

ICMR issues advisory on CRISPR technology-based SARS CoV-2 test

ICMR could derail world’s largest trial

Odisha, Goa swear by plasma therapy despite ICMR’s note

Free Covid vaccine, 19 lakh jobs: BJP releases Bihar manifesto

IIT Kharagpur's 'Covirap' diagnostic machine gets ICMR certification

Plasma therapy is likely to be off Covid treatment protocol: ICMR

Virus can hit recovered Covid patients once antibodies start depleting: ICMR

‘Post Trials’ data, ICMR needs to revise Covid-19 drug regimen’

ICMR: Three re-infection cases in India, 24 globally

DCGI nod to Phase-1 human trials of 'antisera' with potential to treat Covid-19

No benefit of plasma therapy arresting mortality in moderate to severe Covid-19 cases: ICMR